A company specialising in providing HR software and technology to its customers globally is to create 300 jobs at existing centres in Cork and Kilkenny.
In Waterford, meanwhile, up to 40 jobs are being created at a multinational medical products company already employing more than 630 people.
Minister for Jobs, Enterprise, and Innovation Mary Mitchell O’Connor was in Ballincolliog, Co Cork, yesterday to confirmed 300 jobs at CoreHR’s bases in Cork and Kilkenny.
They will be created over the next three years.
CoreHR has 250 employees and specialises in cloud-based human capital management and payroll software.
It will fill the positions across a wide variety of roles, including product and development, professional services, customer support, sales, and marketing.
Ms Mitchell-O’Connor said the jobs boost was “great news for the country”.
“My priority is to ensure an environment for jobs growth is developed right across the country and in particular the regions of Ireland,” she said.
“I believe only a strong economy supporting people at work can pay for the services needed to create a fair society.”
CoreHR chief executive John Goulding said the company had carved out a strong presence across a wide range of sectors to become a world leader at the forefront of developing innovative HR software solutions.
“After a number of years of strong performance, including 30% revenue growth last year, I am very much looking forward to the next stage of our success story, to expanding our talented team and to continuing our global growth strategy,” he said.
Julie Sinnamon, chief executive of Enterprise Ireland, which supports the expansion, said innovation is central to CoreHR’s success in competing and winning global customers.
“Enterprise Ireland looks forward to continuing to support CoreHR’s growth ambitions as they create new jobs,” she said.
Cork Chamber chief excutive Conor Healy said the news was “hugely positive” and showed Cork was a centre for hi-tech growth.
Meanwhile, international medical products giant Sanofi is expanding its base in the southeast.
It is to change the name of its Irish operation from Genzyme Waterford to Sanofi Waterford next month.
“Since Sanofi acquired Genzyme globally in 2011, the Waterford operation has been increasingly closely-integrated within Sanofi Industrial Affairs so this is the logical next step as we plan for the future and build on the track record of achievement and growth here since 2001,” said Ruth Beadle, site head at Sanofi Waterford.
Genzyme has been in Waterford since 2001.
Products for people with rare diseases are among those on the production line locally.
The site expansion continues at the plant which will allow the first Sanofi diabetes products and medical devices to be manufactured there.
© Irish Examiner Ltd. All rights reserved